Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Innova Captab Ltd

Healthcare | Small Cap

Innova Captab Ltd Health Insights
Health Score : 7.36Health Score : 7.36

Innova Captab Ltd shows a strong financial profile, marked by exceptional growth and profitability. The company is rapidly expanding its sales and profits while maintaining very healthy margins and returns for its investors. Its financial stability is a key strength, as it operates with very little debt, reducing risks associated with borrowing. This allows the company to reinvest its earnings back into the business. A notable area of focus is the company's operational efficiency; while it is growing its assets significantly, turning those assets into revenue is a developing aspect. It also takes a considerable amount of time to collect payments from customers. The future outlook appears positive, driven by aggressive growth strategies, though it is dependent on the successful utilization of its substantial new investments.

Latest Report

View All
Q3 & 9M FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Innova Captab Ltd Health Insights
Health Score : 7.36Health Score : 7.36

Innova Captab Ltd shows a strong financial profile, marked by exceptional growth and profitability. The company is rapidly expanding its sales and profits while maintaining very healthy margins and returns for its investors. Its financial stability is a key strength, as it operates with very little debt, reducing risks associated with borrowing. This allows the company to reinvest its earnings back into the business. A notable area of focus is the company's operational efficiency; while it is growing its assets significantly, turning those assets into revenue is a developing aspect. It also takes a considerable amount of time to collect payments from customers. The future outlook appears positive, driven by aggressive growth strategies, though it is dependent on the successful utilization of its substantial new investments.

Latest Report

View All
Q3 & 9M FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Overvalued

P/E RATIO (TTM)

64.90

Overvalued

Industry Median

28.62

Overvalued
Overvalued

Small Cap Median

27.17

Overvalued

P/E RATIO

38.55

P/B RATIO

4.97

Overvalued

Industry Median

3.17

Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

3.33

Neutral

Industry Median

3.42

Neutral
Overvalued

Small Cap Median

2.55

Overvalued

Others

Neutral

PEG RATIO

1.18

Neutral
Overvalued

EV/EBITDA RATIO

22.57

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹949.55 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Concall Report2nd Feb 26

Q3 & 9M FY26 Earnings Conference Call

BULLISH SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is in a phase of exceptional and robust expansion. It is achieving outstanding growth in revenue, operating profits, and net income, indicating strong market demand and effective operational scaling. This high growth is supported by a significant increase in the company's asset base, reflecting aggressive investment in its future. The earnings available to each shareholder are also growing at an excellent rate, signaling that this expansion is creating substantial value.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate94.8915.6116.7415.0831.03
Operating Profit Growth Rate77.7818.7535.0920.7830.65
Earnings Per Share (EPS) Growth85.36-97.3416.4535.99.91
Asset Growth Rate55.4122.4386.9319.1517.16
Net Income Growth Rate88.246.2538.2436.1710.16
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 6.80

The company's financial strategy is clearly focused on long-term growth over short-term shareholder payouts. It is generating excellent earnings and cash flow per share, and its intrinsic book value is increasing impressively. However, this value is being retained within the company, as it does not pay dividends and is channeling a very large amount of cash into capital expenditures. This reflects an aggressive reinvestment strategy aimed at expanding its operational base for future returns.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)53.3313.7516.4922.4624.74
Cash Earnings Per Share (Cash EPS)6016.4619.326.8432.63
Book Value Per Share174.1757.71145.79168.25191.4
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)807828717261
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is exceptional across all key measures. It demonstrates a superior ability to control costs, resulting in strong margins from its sales. More importantly, it is highly effective at generating high returns on the money invested by both shareholders and lenders, as well as on its entire asset base. This all-around excellent performance in turning revenue and capital into profit indicates a highly efficient and well-managed business with a strong competitive advantage.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin10.9911.1212.7712.9412.15
Return on Capital Employed (ROCE)3124191515
Return on Equity (ROE)30.6224.5511.3113.3512.92
Return on Assets (ROA)16.716.1911.711.8613.23
Operating Margin11.9912.3114.2514.9514.91
Net Margin7.997.348.710.298.65
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.67

The company's overall operational efficiency presents a mixed picture with some notable challenges. While it manages its inventory at an acceptable speed, there are difficulties in other key areas. The company is not generating a high volume of sales from its investments in fixed and total assets, suggesting these resources may be underutilized. Additionally, it takes a relatively long time to collect payments from its customers, which can tie up cash. These factors point to areas where operational performance is lagging.

PoorFixed Asset Turnover RatioPoor
AverageInventory Turnover RatioAverage
WeakReceivables Turnover RatioWeak
AverageDays Sales in Inventory RatioAverage
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio4.385.063.021.51.94
Inventory Turnover Ratio6.56.737.236.155.83
Receivables Turnover Ratio4.553.873.914.014.24
Days Sales in Inventory Ratio56.1554.2350.4859.3562.61
Receivable Days80.2294.3293.3591.0286.08
Capital Turnover Ratio2.892.531.041.031.25
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company's ability to cover its financial obligations is strong in some areas but reflects its strategic choices in others. Its earnings are more than sufficient to handle its interest payments, which is a very positive sign of financial health. On the other hand, the company is not currently paying dividends. This indicates a policy of retaining all profits, likely to fund its aggressive growth and expansion plans, rather than distributing them to shareholders.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio15.335.67.1986.512.06
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits exceptional long-term financial stability. Its reliance on debt is extremely low, with the vast majority of its assets being funded by equity. This conservative financial structure significantly reduces the risk associated with interest payments and loan repayments, making the company highly resilient to economic downturns and rising interest rates. Stakeholders can view this as a sign of a very strong and secure financial foundation, with minimal risk of bankruptcy due to debt.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.250.330.20.20.17
Debt to Equity Ratio0.330.490.250.250.2
Equity Ratio0.750.670.80.80.83
Debt To Asset Ratio0.120.190.160.160.12
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 5.86

The company demonstrates a satisfactory ability to meet its short-term financial obligations. It holds enough current assets to cover immediate liabilities, indicating a degree of financial flexibility. However, its reliance on turning inventory and receivables into cash is notable, as its immediate cash reserves and cash generated from operations are less robust. This suggests a manageable but tight balance in its day-to-day financial management, where its ability to sell products and collect payments is crucial for maintaining liquidity.

AverageCurrent RatiosAverage
GoodQuick RatiosGood
WeakCash RatiosWeak
WeakOperating Cash Flow RatiosWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.321.712.251.971.77
Quick Ratio0.891.311.731.41.24
Cash Ratio0.010.070.320.190.01
Operating Cash Flow Ratio0.20.230.530.180.22
01.

Current Ratios

02.

Quick Ratios

03.

Cash Ratios

04.

Operating Cash Flow Ratios

Peer Comparison With 21 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
2Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
3Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
4Aarti Pharmalabs Ltd7.4635.90Neutral369.0019.44175.00
5Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
6Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
7RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
8Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
9Alembic Ltd7.067.28Undervalued90.004.85317.00
10SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
11Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
12Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
13IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
14Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
15Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
16Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
17Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
18Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
19Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
20Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

Management effectiveness presents a mixed profile. The company demonstrates strong execution on growth, with robust multi-year sales and profit expansion, stable operating margins, and efficient working capital management. This is further supported by a significant increase in institutional shareholding and a much-improved debt-to-equity ratio following a recent capital infusion. However, these strengths are counterbalanced by significant weaknesses in capital efficiency. Key return metrics like ROCE and ROE are on a clear downward trend, and asset turnover has weakened considerably. The policy of zero dividend payout and volatile interest coverage also weigh on the assessment, indicating that while growth is being pursued aggressively, profitability on invested capital is deteriorating.

Category Metric Value Assessment
PROS Compounded Sales Growth (5Y) 32% strong
Compounded Profit Growth (5Y) 33% strong
Debt/Equity Ratio (Mar 2024) 0.29 improving
DII Holding (Dec 23 -> Mar 24) 10.31% -> 20.78% very strong
CONS ROCE % (Mar 2022 -> Mar 2024) 31% -> 19% declining
Return on Equity (Last Year) 14% weak
Asset Turnover (Mar 2023 -> Mar 2024) 1.31 -> 0.82 declining
Dividend Payout % 0% poor
GoodFinancial Performance & GrowthGood
WeakCapital Efficiency & ReturnsWeak
GoodFinancial Health & PrudenceGood
ExcellentShareholding & Ownership StructureExcellent
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The primary risk stems from the company's aggressive capital expenditure, which has led to consistently negative free cash flow over the past three years. The cash outflow for investments far exceeds the cash generated from operations, creating a reliance on external financing activities to fund growth ambitions. While the company's recent IPO has bolstered its cash position and reduced debt, this high-capex strategy is also a likely cause of declining capital efficiency ratios (ROCE, ROE). This combination of negative cash flow and weakening return metrics presents a moderate risk, indicating that while the company is investing for the future, it is in a financially intensive and vulnerable phase.

PoorFree Cash Flow StrainPoor
01.

Free Cash Flow Strain

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10944.43Bullish
  3. SMA 20938.92Bullish
  4. SMA 50947.53Bullish
  5. EMA 10945.58Bullish
  6. EMA 20943.77Bullish
  7. EMA 50937.26Bullish
  8. DEMA 10949.38Bullish
  9. DEMA 20945.16Bullish
  10. DEMA 50954.09Bearish
  11. TEMA 10952.42Bearish
  12. TEMA 20945.37Bullish
  13. TEMA 50949.28Bullish
  14. MACD1.63Bullish
  15. ADX19.76Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI54.76Neutral
  3. CCI81.32Neutral
  4. ROC 93.32Bullish
  5. ROC 141.20Bullish
  6. ROC 25-1.21Bearish
  7. Stoch K83.41Overbought
  8. Stoch D82.90Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper961.86Neutral
  3. BB Middle938.92Neutral
  4. BB Lower915.99Neutral
  5. ATR10.85Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI64.42Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10938.98Bullish
  3. SMA 20946.73Bullish
  4. SMA 50920.94Bullish
  5. EMA 10944.31Bullish
  6. EMA 20942.15Bullish
  7. EMA 50923.82Bullish
  8. DEMA 10945.37Bullish
  9. DEMA 20949.83Bullish
  10. DEMA 50955.02Bearish
  11. TEMA 10946.65Bullish
  12. TEMA 20943.19Bullish
  13. TEMA 50957.89Bearish
  14. MACD4.92Bearish
  15. ADX32.70Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI56.01Neutral
  3. CCI28.41Neutral
  4. ROC 91.28Bullish
  5. ROC 14-0.96Bearish
  6. ROC 25-0.39Bearish
  7. Stoch K60.82Neutral
  8. Stoch D59.77Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper972.09Neutral
  3. BB Middle946.72Neutral
  4. BB Lower921.36Neutral
  5. ATR16.23Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI33.61Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10946.40Bullish
  3. SMA 20934.60Bullish
  4. SMA 50890.92Bullish
  5. EMA 10942.33Bullish
  6. EMA 20930.28Bullish
  7. EMA 50893.96Bullish
  8. DEMA 10949.95Bullish
  9. DEMA 20955.42Bearish
  10. DEMA 50952.04Bearish
  11. TEMA 10944.33Bullish
  12. TEMA 20956.10Bearish
  13. TEMA 50N/AN/A
  14. MACD17.91Bearish
  15. ADX41.78Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI58.95Neutral
  3. CCI47.96Neutral
  4. ROC 90.17Bullish
  5. ROC 144.94Bullish
  6. ROC 2510.81Bullish
  7. Stoch K55.67Neutral
  8. Stoch D49.38Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper984.59Neutral
  3. BB Middle934.60Neutral
  4. BB Lower884.61Neutral
  5. ATR27.02Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI80.28Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10931.76Bullish
  3. SMA 20894.07Bullish
  4. SMA 50830.50Bullish
  5. SMA 100759.87Bullish
  6. SMA 200769.40Bullish
  7. EMA 10928.90Bullish
  8. EMA 20904.17Bullish
  9. EMA 50846.08Bullish
  10. EMA 100801.76Bullish
  11. EMA 200788.30Bullish
  12. DEMA 10952.92Bearish
  13. DEMA 20948.26Bullish
  14. DEMA 50919.17Bullish
  15. DEMA 100845.03Bullish
  16. DEMA 200792.70Bullish
  17. TEMA 10954.12Bearish
  18. TEMA 20952.15Bearish
  19. TEMA 50955.44Bearish
  20. TEMA 100905.54Bullish
  21. TEMA 200811.13Bullish
  22. MACD33.01Bullish
  23. ADX31.32Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI67.20Neutral
  3. CCI86.56Neutral
  4. ROC 1410.31Bullish
  5. ROC 258.91Bullish
  6. Stoch K72.47Neutral
  7. Stoch D76.00Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper978.82Neutral
  3. BB Middle894.06Neutral
  4. BB Lower809.31Neutral
  5. ATR37.66Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI87.86Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20750.72Bullish
  3. SMA 50785.84Bullish
  4. EMA 20789.38Bullish
  5. EMA 50778.17Bullish
  6. DEMA 20826.73Bullish
  7. DEMA 50780.65Bullish
  8. TEMA 20880.14Bullish
  9. TEMA 50N/AN/A
  10. MACD36.01Bullish
  11. ADX25.83Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.66Neutral
  3. CCI110.16Overbought
  4. ROC 1438.62Bullish
  5. ROC 2536.74Bullish
  6. Stoch K83.42Overbought
  7. Stoch D80.03Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper921.21Overbought
  3. BB Middle750.72Neutral
  4. BB Lower580.24Neutral
  5. ATR68.58High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.62Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6729.31Bullish
  3. SMA 12787.36Bullish
  4. SMA 24804.51Bullish
  5. EMA 6765.74Bullish
  6. EMA 12769.75Bullish
  7. EMA 24742.36Bullish
  8. DEMA 6768.58Bullish
  9. DEMA 12767.31Bullish
  10. DEMA 24N/AN/A
  11. TEMA 6795.21Bullish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX29.89Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSIN/AN/A
  3. CCIN/AN/A
  4. ROC 2579.75Bullish
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1072.21Neutral
  3. BB Middle836.79Neutral
  4. BB Lower601.38Neutral
  5. ATR140.55High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI52.62Neutral